Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

FDA approves IND for cystic fibrosis drug

Aug. 13, 1997

Bayer reports LTB4 synthesis inhibitors for asthma

Aug. 12, 1997

First European clinical trials of pranlukast reported

Aug. 11, 1997

Orally active PDE IV inhibitors from Merck Frosst

Aug. 11, 1997

Allegra now available in Canada

Aug. 6, 1997

Anti-IL-4 MAb effective in murine model of asthma

Aug. 5, 1997

Leukotriene synthesis inhibitors in development at Bayer

Aug. 5, 1997

Nonpeptide NK3 antagonists from SmithKline Beecham

Aug. 5, 1997

HMR discovers elastase inhibitors and prodrugs thereof

July 31, 1997

Device for snoring cleared by FDA

July 30, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...